Patients with a histologically, radiologically or haematologically confirmed malignancy whose pain is judged by the investigator to be caused by the malignancy 
Patients must have been on a stable daily dose of weak opioids or strong opioids for at least 72 hours prior to the start the study and must remain at the same dosage for the duration of the study 
Patients must have a VAS (Visual analog scale) >=40mm 

NCT00576173_inc_T1
Procedure
histologically
NCT00576173_inc_T2
Procedure
radiologically
NCT00576173_inc_T3
Procedure
haematologically
NCT00576173_inc_T4
Value
confirmed
NCT00576173_inc_T5
Condition
malignancy
NCT00576173_inc_T6
Condition
pain
NCT00576173_inc_T7
Scope
histologically, radiologically or haematologically
NCT00576173_inc_T8
Drug
weak opioids
NCT00576173_inc_T9
Drug
strong opioids
NCT00576173_inc_T10
Temporal
at least 72 hours prior to the start the study
NCT00576173_inc_T11
Scope
weak opioids or strong opioids
NCT00576173_inc_T12
Measurement
VAS (Visual analog scale)
NCT00576173_inc_T13
Value
>=40mm